期刊文献+

生物可吸收支架的最新研究进展 被引量:7

下载PDF
导出
摘要 目前,针对冠心病的治疗,形成了从生活方式的改善到理想化的药物治疗,再到内科介入治疗和外科手术治疗的优化体系。在这一体系中,心脏支架扮演着重要的角色。30余年来,支架经历了从无到有,再到广泛使用的过程,经历了四次技术革命[1]。
出处 《中国介入心脏病学杂志》 2016年第9期521-525,共5页 Chinese Journal of Interventional Cardiology
基金 北京市医院管理局临床医学发展专项(ZYLX201303) 北京市医院管理局"登峰"计划专项(DFL20150601) 国家临床重点专科建设项目(2013-2014年度)
  • 相关文献

参考文献3

二级参考文献20

  • 1高润霖.药物洗脱支架研究现状及进展[J].中国实用内科杂志,2006,26(8):1121-1123. 被引量:19
  • 2Smits P. Evaluation of the Absorb everolimus during Bioresorbable Vascular Scaffold (Absorb BVSi in the treatment of patients with de novo native coronary artery lesions: 3 year clinical results of the ABSORB cohort B I trial [ J ]. J Am Coll Cardiol,2012,60(17_S) : B11.
  • 3Bartorelli A. ABSORB EXTEND: an interim report on the 12-month clinical outcomes from the first 250 patients enrolled [ J ]. J Am Coil Cardiol, 2012,60 (17_S) :B10.
  • 4Tsuji T, Tamai H, Igaki K, et al. One year follow-up biodegradable self-expanding stent implantation in humans. J AmColl Cardiol, 2001, 37:A47.
  • 5Erbel R, Di Mario C, Bartunek J, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet, 2007, 369:1869-1875.
  • 6Ghimire G, Spiro J, Kharbanda R, et al. Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. Euro Intervention, 2009, 4:481-484.
  • 7Waksman R, Erbel R, Di Mario C, et al. Early- and long- termintravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. J Am Coil Cardiol Intv, 2009, 2:312-320.
  • 8Ormiston JA, Serruys PW, Regar E, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single denovo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet, 2008, 371:899-907.
  • 9Dudek D, Onuma Y, Ormiston JA, et al. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. Eurolntervention, 2012, 7:1060-1061.
  • 10Onuma Y, Serruys PW, Gomez J, et al. Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent. Catheter Cardiovasc Interv, 2011, 78:3 - 12.

共引文献11

同被引文献16

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部